Inhibition of the fast Na+ inward current by the Ca2+ channel blocker tiapamil
- PMID: 2434733
Inhibition of the fast Na+ inward current by the Ca2+ channel blocker tiapamil
Abstract
The inhibitory effect of the phenylalkylamine-type Ca2+-entry blocker, tiapamil, on the fast Na+ inward current was investigated in guinea-pig papillary muscles by measuring the maximum upstroke velocity (dV/dt)max of transmembrane action potentials. Tiapamil inhibited (dV/dt)max at concentrations above 10(-6) M, with an IC50 value of 7 X 10(-5) M (1 Hz stimulation frequency, 5.9 mM extracellular K+). Verapamil was less potent in depressing upstroke velocity. Inhibition of the dV/dtmax strongly depended on the frequency at which the muscles were stimulated ("use-dependent" effect). There was no evidence that tiapamil acts in a potential-dependent manner like local anesthetics. The results indicate that the Ca2+-entry blocker tiapamil has additional pharmacological properties, which may contribute to its usefulness in the treatment of ventricular arrhythmias.
Similar articles
-
Bioelectrical and mechanical effects of tiapamil (Ro 11-1781) on isolated guinea pig myocardium.Cardiovasc Res. 1986 Jan;20(1):42-51. doi: 10.1093/cvr/20.1.42. Cardiovasc Res. 1986. PMID: 3708640
-
Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.Arzneimittelforschung. 1981;31(9):1393-401. Arzneimittelforschung. 1981. PMID: 7197945
-
Depressant action of Ca-antagonists on slow action potentials in guinea pig ventricular muscles.Acta Physiol Hung. 1986;68(1):51-9. Acta Physiol Hung. 1986. PMID: 3751620
-
Asocainol, a new antiarrhythmic drug with natrium- and calcium-antagonistic effects on ventricular myocardium.J Cardiovasc Pharmacol. 1984 Nov-Dec;6(6):1027-35. J Cardiovasc Pharmacol. 1984. PMID: 6084758
-
Tiapamil--a new calcium antagonist.S Afr Med J. 1985 Jun 1;67(22):881-3. S Afr Med J. 1985. PMID: 3890216 Review.
Cited by
-
Calcium channel antagonists, Part I: Fundamental properties: mechanisms, classification, sites of action.Cardiovasc Drugs Ther. 1987 Dec;1(4):411-30. doi: 10.1007/BF02209083. Cardiovasc Drugs Ther. 1987. PMID: 2856470 Review.
-
Calcium channel antagonists. Part V: Second-generation agents.Cardiovasc Drugs Ther. 1988 Jul;2(2):191-203. doi: 10.1007/BF00051234. Cardiovasc Drugs Ther. 1988. PMID: 3154705 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous